Login / Signup

Effect of Diacerein on Metabolic Control and Inflammatory Markers in Patients with Type 2 Diabetes Using Antidiabetic Agents: A Randomized Controlled Trial.

Glaucia S TresSandra C FuchsFabiana PiovesanPatricia Koehler-SantosFernanda Dos S PereiraSuzi A CameyHugo K LisboaLeila Beltrami Moreira
Published in: Journal of diabetes research (2018)
This trial is registered with Brazilian Clinical Trials Registry (ReBEC) number RBR-29j956.
Keyphrases
  • clinical trial
  • phase ii
  • phase iii
  • study protocol
  • open label
  • double blind
  • randomized controlled trial